Basically the move from $5 on was all ponatinib. back of the envelope, my guess is the market is currently valuing ponatinib at something around $14, rida prob a $1, and around $3/4 for AP113. Does that sound right to you?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.